MET encodes a receptor tyrosine kinase c-MET for hepatocyte growth factor (HGF). The
specific combination of c-MET and HGF activates downstream signaling pathways to trigger …

The MET/hepatocyte growth-factor (HGF) signaling pathway plays a key role in the
processes of embryogenesis, wound healing, and organ regeneration. Aberrant activation of …

MET, the receptor tyrosine kinase (RTK) for hepatocyte growth factor, is a proto-oncogene
involved in embryonic development and throughout life in homeostasis and tissue …

MET is located on chromosome 7q31 and is a proto-oncogene that encodes for hepatocyte
growth factor (HGF) receptor, a member of the receptor tyrosine kinase (RTK) family. HGF …

The hepatocyte growth factor (HGF) and its receptor, the transmembrane tyrosine kinase
cMET, promote cell proliferation, survival, motility, and invasion as well as morphogenic …

MET is a versatile receptor tyrosine kinase within the human kinome which is activated by its
specific natural ligand hepatocyte growth factor (HGF). MET signaling plays an important …

The receptor tyrosine kinase c-MET and its ligand, hepatocyte growth factor (HGF), regulate
multiple cellular processes that stimulate cell proliferation, invasion and angiogenesis. This …

Background. c‐MET is a receptor tyrosine kinase receptor (RTK) for the hepatocyte growth
factor (HGF). The binding of HGF to c‐MET regulates several cellular functions …

Introduction: Under normal conditions, hepatocyte growth factor (HGF)-induced activation of
its cell surface receptor, the Met tyrosine kinase (TK), is tightly regulated by paracrine ligand …

The hepatocyte growth factor (HGF)–mesenchymal-epithelial transition factor (MET)
pathway has a key role in carcinogenesis; it is implicated in proliferation, inhibition of …